MAPK3 and breast neoplasm: HBXIP up-regulates some membrane-bound complement regulatory proteins through phosphorylated extracellular signal-regulating kinase 1/2 (p-ERK1/2)/NF-κB signaling to accelerate breast tumor growth[21].